Clinical trial
A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Safety and Efficacy Trial of a Vaginal Matrix Ring With Dapivirine for the Prevention of HIV-1 Infection in Women
NCT01337583 is registered in ClinicalTrials.gov with International Partnership for Microbicides, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Safety and Efficacy Trial of a Vaginal Matrix Ring With Dapivirine for the Prevention of HIV-1 Infection in Women
- Lead sponsor
- International Partnership for Microbicides, Inc.
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- July 31, 2011
- Completion date
- July 31, 2014
- Enrollment
- 0 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.